A detailed history of Compagnie Lombard Odier S Cm A transactions in Abb Vie Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 346,409 shares of ABBV stock, worth $62.1 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
346,409
Previous 328,710 5.38%
Holding current value
$62.1 Million
Previous $56.4 Million 21.33%
% of portfolio
1.12%
Previous 1.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $2.9 Million - $3.53 Million
17,699 Added 5.38%
346,409 $68.4 Million
Q2 2024

Jul 18, 2024

SELL
$154.79 - $180.76 $853,512 - $996,710
-5,514 Reduced 1.65%
328,710 $56.4 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $538,113 - $613,130
3,367 Added 1.02%
334,224 $60.9 Million
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $3.22 Million - $3.63 Million
23,408 Added 7.61%
330,857 $51.3 Million
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $1.02 Million - $1.18 Million
-7,655 Reduced 2.43%
307,449 $45.8 Million
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $4.84 Million - $6.02 Million
-36,492 Reduced 10.38%
315,104 $42.5 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $9.84 Million - $11.3 Million
-68,023 Reduced 16.21%
351,596 $56 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $1.45 Million - $1.74 Million
-10,473 Reduced 2.44%
419,619 $67.8 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $5.53 Million - $6.35 Million
-41,232 Reduced 8.75%
430,092 $57.7 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $3.09 Million - $3.92 Million
-22,428 Reduced 4.54%
471,324 $72.2 Million
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $8.58 Million - $10.6 Million
-65,024 Reduced 11.64%
493,752 $80 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $7.24 Million - $9.17 Million
-67,437 Reduced 10.77%
558,776 $75.7 Million
Q3 2021

Oct 28, 2021

SELL
$106.4 - $120.78 $47.6 Million - $54 Million
-447,080 Reduced 41.65%
626,213 $67.6 Million
Q2 2021

Jul 15, 2021

BUY
$105.21 - $117.21 $85,535 - $95,291
813 Added 0.08%
1,073,293 $121 Million
Q1 2021

Apr 23, 2021

SELL
$102.3 - $112.62 $12.1 Million - $13.3 Million
-118,304 Reduced 9.93%
1,072,480 $116 Million
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $6.22 Million - $8.39 Million
-77,235 Reduced 6.09%
1,190,784 $128 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $1.32 Million - $1.54 Million
15,319 Added 1.22%
1,268,019 $111 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $9.66 Million - $12.9 Million
131,721 Added 11.75%
1,252,700 $123 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $2.53 Million - $3.83 Million
-39,159 Reduced 3.38%
1,120,979 $85.4 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $2.71 Million - $3.39 Million
-37,549 Reduced 3.14%
1,160,138 $103 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $15 Million - $18.1 Million
-238,874 Reduced 16.63%
1,197,687 $90.7 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $16.4 Million - $21 Million
249,688 Added 21.04%
1,436,561 $104 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $1.53 Million - $1.8 Million
19,801 Added 1.7%
1,186,873 $95.6 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $10.3 Million - $12.7 Million
-132,291 Reduced 10.18%
1,167,072 $108 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $1.73 Million - $1.92 Million
-19,436 Reduced 1.47%
1,299,363 $123 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $889,989 - $1.05 Million
9,913 Added 0.76%
1,318,799 $122 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $14.9 Million - $20 Million
-162,331 Reduced 11.03%
1,308,886 $124 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $16.2 Million - $17.8 Million
-181,384 Reduced 10.98%
1,471,217 $142 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $19.4 Million - $24.8 Million
-278,256 Reduced 14.41%
1,652,601 $147 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,930,857
1,930,857 $140 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.